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INTRODUCTION
Distribution policy is a key factor for achieving 
the company goals and a continuation of the ideas 
underlying the marketing strategy, i.e. possibly the 
fullest and greatest customer satisfaction. The main 
objective of the distribution policy is to ensure the 
movement of goods from the manufacturers to the 
customers at minimum expenses. This directly links 
distribution with the economic concept for better 
supply management, resource saving and cuts in the 
total expenses for servicing the delivery of the prod-
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The distribution solutions, which are part of the distribution and logistics policy of Sopharma Trading AD, 
play a key role for the overall success of the company. Distribution in itself is an important element that 
takes time to build and represents a strong corporate linking with multiple intermediaries. Creating effec-
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ucts and their sale at a competitive price. The pur-
pose of the distribution policy is to organise the sys-
tem for product distribution in an optimal way. “Dis-
tribution creates favourable opportunities for the 
proper products to be at a particular place, at a par-
ticular time at competitive prices” (1).
THE OBJECTIVE of this study is to analyse 
the main attributes and specifics of the distribution 
policy of Sopharma Trading AD. 
MATERIALS AND METHODS
The methodological approach to the subject 
includes document analysis. The materials that are 
used are company reports and data from IMS Health 
Bulgaria, regarding the distribution policy of So-
pharma Trading AD.
General description of the company
Sopharma Trading AD is a joint stock company 
registered in Bulgaria under the Commerce Act. The 
main activity of Sopharma Trading AD is wholesale 
and retail trade in medicinal products, sanitary and 
hygiene products, food supplements and cosmetics at 
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a total of more than 700 items. With its five Region-
al Distribution Centres the company has a 100% na-
tional coverage.  It supplies 3 500 pharmacies and 350 
healthcare facilities. Sopharma Trading AD offers a 
pre-distribution service: storage and logistic servic-
es of pharmaceutical products as well as a variety of 
marketing services for Bulgarian and foreign manu-
facturers and importers of medicinal products (2, 4). 
The company’s revenue consists of the income 
from product sales, sale of medical equipment and 
revenue from pre-distribution services, marketing 
and other services.  Sopharma Trading AD operates 
under one-tier management system which is gov-
erned by a board of directors of three members. On 
the territory of the Republic of Bulgaria the company 
has five Regional Distribution Centres respectively in 
the cities of Sofia, Varna, Burgas, Plovdiv and Veliko 
Tarnovo thus providing 100% coverage of the coun-
try. Sopharma Trading AD is founder of the Bulgar-
ian Association of Pharmaceutical Wholesalers (4). 
Market position
All sales of Sopharma Trading AD are per-
formed on the territory of Bulgaria. The company 
realises sales in two market segments – pharmacies 
and hospitals. Two commercial teams function with-
in the market of pharmacies: General Portfolio and 
Featured Products.  In the hospital segment there are 
three sales divisions: Medicinal Products, Consum-
ables, Medical devices and equipment. In addition to 
the distribution of products to retailers Sopharma 
Trading AD sells medicinal products to other whole-
salers and provides services such as storage and lo-
gistics (2,3). 
Distribution of medicinal products is continu-
ing to consolidate. The top four companies serve 
81.84% of the pharmaceutical market, due to the 
compactness of their activity. The market share of 
Sopharma Trading AD from the pharmaceutical 
market based on IMS Health data for 2012 is 21.6%, 
and by 06.2013 it is 22.05%. The market share of So-
pharma Trading AD for 2012 in terms of value is 
19.5% for the pharmacy market and 35.3% for the 
hospital market. 
Sopharma Trading AD is a leader in the hospi-
tal market segment and realises growth in sales. The 
determining factors being financial stability of the 
company, the ability to meet the needs for funding 
of the sector, as well as good relationships with man-
ufacturers. A huge impact is also made by the good 
positions gained at decentralised tenders for expen-
sive medicinal products (2,3). 
Despite the highly competitive environment, 
in 2012 Sopharma Trading AD succeeded in keep-
ing it is leading position on the Bulgarian pharma-
ceutical market with a market share of 21.6% (Fig.1). 
After the investments in logistics, marketing servic-
es and programmes, where customer satisfaction is 
leading, an increasing number of manufacturers and 
pharmaceutical companies identify Sopharma Trad-
ing AD as the most reliable and professionally work-
ing distributor and approach the company with of-
fers for joint programmes focused on improvement 
in the quality of life of the Bulgarian patient.
Determinants of the good results of Sopharma 
Trading AD are the continuing market growth and 
the diversification of both the product portfolio and 
the customers’ channels. Increasing the revenue and 
retaining and growing customers are interdependent 
on faster deliveries, better services and better prices 
through effective logistics. Sopharma Trading AD is 
a progressive distribution company which constantly 
seeks ways to satisfy the changing needs of custom-
ers as well as to add value to the target corporate cli-
ents (2). 
Sopharma Trading AD sells both locally man-
ufactured products and imported ones (chiefly from 
EU countries). Imported products dominate and 
their relative share has reached 80% by June 2013. 
Sopharma Trading AD can follow the market trends 
and keep good business relationships with all manu-
Fig. 1. Value market share of distribution companies from 
the total pharmaceutical market for 2012
*Data from IMS Health Bulgaria
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facturers on the Bulgarian market rather than exert 
influence on this distribution of sales. 
The sales structure of Sopharma Trading AD, 
with small exceptions, corresponds with the classi-
fication of the manufacturers on the pharmaceuti-
cal market. Top 20 of the manufacturers of medici-
nal products make up 56% of the total market sales 
in 2012 whereas in the sales structure of Sopharma 
Trading AD, these manufacturers account for 57% 
of sales. These scores are the result of purposeful 
and consistent work of the company with all leading 
pharmaceutical manufacturers present on the Bul-
garian market (3,4).  
Distribution services
The main efforts for change in the business pro-
cesses are towards optimisation and increase in the 
quality of the distribution policy. At present the cus-
tomer service stages are: (1) taking orders, (2) picking 
from the warehouse, (3) delivery to the customer’s 
premises, (4) collecting payments due from custom-
ers. Within the market environment, customer sat-
isfaction with the distribution quality plays a strate-
gic role in achieving a leading market position. This 
factor incorporates (1) accuracy, promptness and ex-
pertise of the employees accepting phone orders, (2) 
cancellations, (3) match between invoice amount and 
batch amount, (4) timely delivery according to the 
transport schedule, (5) quick processing of recalls. In 
this context Sopharma Trading AD chiefly aims at 
stability and predictability of the distribution service 
at an optimal price. 
Other services provided by Sopharma Trading 
AD  
 ❖ Pre-distribution – storage and logistic servic-
ing of pharmaceutical products of Bulgarian 
and foreign companies. Apart from the stan-
dard logistic services, such as storage, the com-
pany provides services specific for the pharma-
ceutical business such as storage of tempera-
ture-sensitive products, destruction of medici-
nal products, a package of financial services, lo-
gistic management of clinical trials and others. 
 ❖ Logistic services for companies conducting 
clinical trials in Bulgaria. The services include 
delivery and storage of trial products as well as 
all procedures connected with their withdraw-
al and destruction.
 ❖ Marketing and advertising services for manu-
facturers – Sopharma Trading AD offers pub-
lishing contracts for its free monthly custom-
er newsletter which is spread among owners of 
pharmacies and pharmacists. It specialises in 
providing useful information about the phar-
maceutical business, medicinal and non-me-
dicinal products. The company offers a varied 
portfolio of marketing services and initiatives 
for partner suppliers and manufacturers to help 
them promote their products on the Bulgarian 
pharmaceutical market.
 ❖ Renting of tangible fixed assets – for some of its 
exclusive partners Sopharma Trading AD offers 
part of its logistics potential to rent (2).
The main advantages of distribution system of 
Sopharma Trading AD involve the following:
1. An automated system for handling and stor-
age of goods was adopted in the regional dis-
tribution centre in Sofia. Logistics warehous-
es were built in Plovdiv and Veliko Tarnovo. 
2. Improved the quality of the website for on-
line ordering so as to create the best working 
environment for the customers, provide addi-
tional information and services through the 
website and encourage them to use this com-
munication channel. 
3. Increased dealers’ efficiency and guaranteed 
connectivity for customers. Introduced fixed 
time periods for taking orders from clients. 
4. Reduced the time for processing of recalls 
and established feedback mechanisms for all 
registered cases. 
5. Reduced number of order cancellations 
mainly through changing the delivery meth-
odology and by establishing a Planning and 
Forecasting Unit.
6. Increased the number of vehicles and deliv-
ery destinations. 
7. Encouraged the use of bank transfers in order 
to ensure better transportation safety and ef-
ficiency of deliveries. 
FINDINGS
1. Sopharma Trading AD steadily sticks to a 
strategy of renovating its portfolio with me-
dicinal products with guaranteed quality and 
long-standing use. 
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2. The company disposes of a broad network of 
affiliates both on the territory of the country 
and worldwide.  
3. The main objective of the distribution policy 
is to spread its positions on the existing mar-
kets and penetrate new markets.  
CONCLUSION
Sopharma Trading AD is one of the leading dis-
tribution companies of medicinal products, medical 
consumables, sanitary and hygiene products, vita-
mins, food supplements and cosmetics. The compa-
ny meets the international requirements and Euro-
pean standards. It is one of the major and preferred 
partners for clients, suppliers, manufacturers and 
investment partners. In order to maintain its lead-
ing position in sales of medicinal products and to in-
crease the market share, the company invests in the 
launch of innovative technical and technological 
solutions.  
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